Literature DB >> 34162386

Universal capability of 3-ketosteroid Δ1-dehydrogenases to catalyze Δ1-dehydrogenation of C17-substituted steroids.

Patrycja Wójcik1, Michał Glanowski1, Agnieszka M Wojtkiewicz1, Ali Rohman2,3,4, Maciej Szaleniec5.   

Abstract

BACKGROUND: 3-Ketosteroid Δ1-dehydrogenases (KSTDs) are the enzymes involved in microbial cholesterol degradation and modification of steroids. They catalyze dehydrogenation between C1 and C2 atoms in ring A of the polycyclic structure of 3-ketosteroids. KSTDs substrate spectrum is broad, even though most of them prefer steroids with small substituents at the C17 atom. The investigation of the KSTD's substrate specificity is hindered by the poor solubility of the hydrophobic steroids in aqueous solutions. In this paper, we used 2-hydroxpropyl-β-cyclodextrin (HBC) as a solubilizing agent in a study of the KSTDs steady-state kinetics and demonstrated that substrate bioavailability has a pivotal impact on enzyme specificity.
RESULTS: Molecular dynamics simulations on KSTD1 from Rhodococcus erythropolis indicated no difference in ΔGbind between the native substrate, androst-4-en-3,17-dione (AD; - 8.02 kcal/mol), and more complex steroids such as cholest-4-en-3-one (- 8.40 kcal/mol) or diosgenone (- 6.17 kcal/mol). No structural obstacle for binding of the extended substrates was also observed. Following this observation, our kinetic studies conducted in the presence of HBC confirmed KSTD1 activity towards both types of steroids. We have compared the substrate specificity of KSTD1 to the other enzyme known for its activity with cholest-4-en-3-one, KSTD from Sterolibacterium denitrificans (AcmB). The addition of solubilizing agent caused AcmB to exhibit a higher affinity to cholest-4-en-3-one (Ping-Pong bi bi KmA = 23.7 μM) than to AD (KmA = 529.2 μM), a supposedly native substrate of the enzyme. Moreover, we have isolated AcmB isoenzyme (AcmB2) and showed that conversion of AD and cholest-4-en-3-one proceeds at a similar rate. We demonstrated also that the apparent specificity constant of AcmB for cholest-4-en-3-one (kcat/KmA = 9.25∙106 M-1 s-1) is almost 20 times higher than measured for KSTD1 (kcat/KmA = 4.71∙105 M-1 s-1).
CONCLUSIONS: We confirmed the existence of AcmB preference for a substrate with an undegraded isooctyl chain. However, we showed that KSTD1 which was reported to be inactive with such substrates can catalyze the reaction if the solubility problem is addressed.

Entities:  

Keywords:  1,2-dehydrogenation; 3-ketosteroid dehydrogenase; 3-ketosteroids; Cholest-4-en-3-one; Cholest-4-en-3-one Δ1-dehydrogenase; Cholesterol metabolism; Diosgenone; KSTD; Δ1-dehydrogenation

Year:  2021        PMID: 34162386     DOI: 10.1186/s12934-021-01611-5

Source DB:  PubMed          Journal:  Microb Cell Fact        ISSN: 1475-2859            Impact factor:   5.328


  29 in total

1.  Concerning the stereochemistry and mechanism of the bacterial C-1,2 dehydrogenation of steroids.

Authors:  H J RINGOLD; M HAYANO; V STEFANOVIC
Journal:  J Biol Chem       Date:  1963-06       Impact factor: 5.157

2.  Characterization of new recombinant 3-ketosteroid-Δ1-dehydrogenases for the biotransformation of steroids.

Authors:  Xiaojun Wang; Jinhui Feng; Dalong Zhang; Qiaqing Wu; Dunming Zhu; Yanhe Ma
Journal:  Appl Microbiol Biotechnol       Date:  2017-06-20       Impact factor: 4.813

Review 3.  The role and mechanism of microbial 3-ketosteroid Δ1-dehydrogenases in steroid breakdown.

Authors:  Ali Rohman; Bauke W Dijkstra
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-13       Impact factor: 4.292

4.  Studies of 3-oxo steroid delta-1-oxydo reductase of Arthrobacter simplex.

Authors:  L Penasse; M Peyre
Journal:  Steroids       Date:  1968-10       Impact factor: 2.668

Review 5.  Application of microbial 3-ketosteroid Δ1-dehydrogenases in biotechnology.

Authors:  Ali Rohman; Bauke W Dijkstra
Journal:  Biotechnol Adv       Date:  2021-04-04       Impact factor: 14.227

6.  Cholest-4-en-3-one-delta 1-dehydrogenase, a flavoprotein catalyzing the second step in anoxic cholesterol metabolism.

Authors:  Yin-Ru Chiang; Wael Ismail; Sébastien Gallien; Dimitri Heintz; Alain Van Dorsselaer; Georg Fuchs
Journal:  Appl Environ Microbiol       Date:  2007-11-09       Impact factor: 4.792

7.  Enhancement of androstadienedione production from progesterone by biotransformation using the hydroxypropyl-beta-cyclodextrin complexation technique.

Authors:  Aranya Manosroi; Suda Saowakhon; Jiradej Manosroi
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

8.  An oxygenase-independent cholesterol catabolic pathway operates under oxic conditions.

Authors:  Po-Hsiang Wang; Tzong-Huei Lee; Wael Ismail; Ching-Yen Tsai; Ching-Wen Lin; Yu-Wen Tsai; Yin-Ru Chiang
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 9.  Catabolism and biotechnological applications of cholesterol degrading bacteria.

Authors:  J L García; I Uhía; B Galán
Journal:  Microb Biotechnol       Date:  2012-02-07       Impact factor: 5.813

View more
  1 in total

1.  Construction of automated high-throughput screening method for finding efficient 3-ketosteroid 1,2-dehydrogenating strains.

Authors:  Menglei Xia; XinYao Yan; Zehui Zan; Fan Yang; Mengjiao Liu; Danni Xue; Yanbing Shen; Min Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-06       Impact factor: 5.560

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.